查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
IV 水化治疗市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按服务、组件、最终用户、地区和竞争细分
市场调查报告书
商品编码
1348900

IV 水化治疗市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按服务、组件、最终用户、地区和竞争细分

IV Hydration Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Service, By Component, By End Users, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 176 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

预计全球静脉水化治疗市场在预测期内将出现令人印象深刻的成长。这可以归因于慢性病发病率的增加、全球手术数量的增加以及静脉注射药物批准数量的增加。此外，预计提供静脉注射疗法的诊所数量不断增加，以增加公司的地理分布，预计将在预测期内推动市场的成长。同样，营养不良盛行率的上升、反应时间的缩短以及与静脉溶液治疗相关的更高的疗效是多年来市场成长的主要驱动力。同样，不接受任何其他形式营养的患者越来越多地采用营养，将进一步推动多年来市场的成长。此外，人口老化日益严重，患者需要透过静脉注射途径餵食营养必需的产品，这将进一步推动预测期内市场的成长。例如，2022年7月，主要检测和健康提供者Sameday Health在美国推出了Inner Beauty IV点滴疗法。该服务将在拥有健康设施的地区的Sameday Health诊所提供，以帮助客户补充胶原蛋白生产，强化指甲和头髮，保持皮肤健康，并提供其他好处。

慢性病盛行率增加

慢性病盛行率的不断上升是全球静脉水化治疗市场成长的关键驱动力。糖尿病、心血管疾病和癌症等慢性疾病会导致脱水和营养缺乏。静脉水化疗法通常用作控制这些疾病的症状和併发症的补充疗法。慢性病患者往往需要频繁住院或门诊治疗，这可能会导致因疾病或治疗本身而脱水。静脉水化疗法是快速有效补充液体和营养物质的有效方法，可降低併发症风险并改善患者预后。此外，静脉水化疗法可以帮助控制癌症患者化疗和放疗的副作用。这些治疗会引起严重的噁心和呕吐，导致脱水和营养不良。静脉水化疗法可以帮助控制这些副作用并改善患者的整体生活品质。随着全球人口老化和慢性病盛行率持续增加，静脉水化疗法的需求预计将增加。这种增长不仅限于医院和诊所，静脉水化疗法已在水疗中心、健身房甚至私人住宅等非医疗环境中变得流行。

市场概况
预测期 2024-2028
2022 年市场规模 27.1亿美元
2028 年市场规模 40.6亿美元
年均复合成长率（2023-2028） 6.86%
成长最快的细分市场 能量助推器
最大的市场 北美洲

健康和预防性医疗保健日益普及

健康和预防性医疗保健的日益普及是全球静脉水化治疗市场成长的重要动力。随着人们健康意识的增强，人们对预防性医疗保健和保持最佳健康的兴趣日益浓厚。静脉水化疗法正在成为实现这一目标的流行方法。静脉水化疗法是增强免疫系统、补充液体和电解质以及改善整体健康的有效方法。它经常被运动员和健身爱好者用来帮助运动或比赛后恢復，以及提高表现。此外，静脉水化疗法也越来越多地被用作对抗老化影响的一种方法，包括疲劳、皱纹和其他老化迹象。它也用于对抗现代社会常见的压力和倦怠的影响。静脉补水疗法作为一种对抗宿醉和时差反应的方法也越来越受欢迎，因为它可以快速补充身体水分并缓解症状。随着对预防性医疗保健和健康服务的需求持续增长，对静脉水化疗法的需求预计也会增加。这种增长也得益于水疗中心和健身中心等非医疗环境中越来越多的使用。

对微创医疗的需求不断成长

对微创医疗的需求不断增长是全球静脉水化治疗市场成长的重要动力。微创医疗是指比传统外科手术风险、疼痛和恢復时间更小的治疗。静脉水化疗法是一种微创治疗，可以提供快速有效的结果，同时将不适或停机时间降至最低。静脉水化疗法是一种非侵入性治疗，涉及透过静脉将液体、电解质和营养物质直接注射到血液中。这使得这些物质能够快速吸收，从而可以快速补充液体和营养并解决广泛的健康问题。静脉水化疗法的微创性质使其成为想要避免手术或其他侵入性治疗的患者的有吸引力的治疗选择。对于因噁心、呕吐或其他消化问题而难以服用口服药物或补充剂的患者来说，它也是一个受欢迎的选择。此外，静脉水化疗法可以在各种环境中进行，包括医院、诊所，甚至家庭环境，这使其成为患者方便的治疗选择。随着微创医疗需求的持续成长，静脉水化治疗的需求也预计会增加。这种增长不仅限于医疗环境，因为静脉水化疗法在水疗中心、健身房和私人住宅等非医疗环境中也越来越流行。

在非医疗环境中越来越多地采用静脉水化疗法

在非医疗环境中越来越多地采用静脉水化疗法是全球静脉水化疗法市场成长的重要动力。静脉水化疗法不再局限于医院和诊所，而是成为水疗中心、健身中心甚至私人住宅等非医疗环境中流行的治疗选择。在非医疗环境中越来越多地采用静脉水化疗法的原因之一是健康和预防性医疗保健的日益普及。在非医疗环境中越来越多地采用静脉水化疗法的另一个原因是便利因素。患者可以在运动或放鬆时在水疗中心或健身中心接受静脉水化治疗，使其成为一种方便有效的治疗方式。此外，行动静脉水化治疗服务的可用性不断增加，也推动了静脉水化治疗在非医疗环境中的采用。这些服务直接为患者提供静脉水化治疗，无论患者在家中或偏远地区，使其更加方便和容易获得。在非医疗环境中越来越多地采用静脉水化疗法预计将继续推动全球静脉水化疗法市场的成长。随着越来越多的人意识到静脉水化疗法的好处以及在非医疗环境中接受治疗的便利性，对这些服务的需求预计将进一步增加。

使用静脉水化疗法治疗 COVID-19

使用静脉水化疗法作为 COVID-19 的治疗方法预计将显着影响全球静脉水化疗法市场的成长。 COVID-19是一种由新型冠状病毒引起的呼吸道疾病，它会导致一些患者脱水和电解质失衡，尤其是重症患者。静脉水化疗法是治疗 COVID-19 的潜在方法，因为它可以帮助解决脱水和电解质失衡问题，进一步改善整体健康并帮助復原。它还可用于提供有助于增强免疫系统和对抗病毒的药物和补充剂。此外，静脉水化疗法已被用于治疗患有其他呼吸道疾病（例如流感和肺炎）的患者，并且在某些情况下已被证明可以改善预后。随着 COVID-19 大流行继续在全球蔓延，作为该疾病潜在治疗方法的静脉水化疗法的需求预计将会增加。这可能会导致静脉水化疗法的研发投资增加，特别是针对 COVID-19 的治疗。此外，越来越多地使用静脉水化疗法治疗 COVID-19 可能会导致医疗机构更多地采用该疗法，甚至可能推动静脉水化治疗服务扩展到非医疗机构。

人口老化加剧

人口老化预计将显着影响全球静脉输液治疗市场的成长。随着年龄的增长，他们的身体吸收营养和液体的效率会降低，导致脱水和其他健康问题。静脉水化疗法是解决老年患者常见脱水和营养缺乏问题的潜在解决方案。静脉水化疗法可以快速有效地将液体、电解质和其他必需营养素直接输送到血液中，绕过消化系统并确保快速吸收。此外，随着老年人口的增长，对家庭医疗保健服务的需求不断增加，其中包括静脉水化疗法。许多老年患者喜欢在自己舒适的家中接受医疗服务，而行动静脉输液治疗服务可以提供这种选择。此外，老年人口更有可能患有癌症、肾臟病和心臟病等慢性疾病，因此增加了静脉补水疗法作为治疗方案一部分的需求。总体而言，不断增长的老龄化人口预计将推动静脉水化疗法的需求，作为老年患者脱水和营养缺乏的解决方案。这种需求可能会导致专门针对所有人口的静脉水化治疗的研究投资增加和不断发展，以及静脉水化治疗服务不断扩展到家庭医疗保健环境。

近期发展

  • 2020 年，DripDrop ORS 是一种口服补液溶液，旨在为因疾病、运动或其他因素而脱水的人提供水合作用和电解质。本产品有多种口味可供选择，可在网路上或指定零售店购买。
  • 2022 年，Vida-Flo 水化站将成为一项特许经营的静脉水化治疗服务，为美国各地的客户提供按需静脉水化治疗。该服务提供一系列静脉输液治疗选项，包括注射维生素的静脉注射和增强免疫力的静脉注射。
  • 2020 年，Nuun 运动电解质片旨在为运动员和活跃人士提供水分和电解质。这些药片溶于水，可以在运动前、运动中或运动后服用，以帮助维持水合和电解质平衡。
  • 2020 年，Reviv Global 成为一家全球特许经营的静脉水化治疗服务公司，为世界各地的客户提供随选静脉水化治疗。该服务提供一系列静脉输液治疗选项，包括注射维生素的静脉注射和增强免疫力的静脉注射。
  • 2020 年，Essential Elements 水合粉是一种粉末状电解质补充剂，旨在为因疾病、运动或其他因素而脱水的人提供水合和电解质。本产品有多种口味可供选择，可在网路上或指定零售店购买。

市场区隔

全球静脉水化治疗市场可以按服务、组件、最终用户和地区进行细分。根据服务，市场可分为免疫增强剂、能量增强剂、皮肤护理等。根据成分，市场可分为紧急医疗保健和常规医疗保健。根据最终用户，市场可分为医院和诊所、健康中心和水疗中心、家庭医疗保健等。

市场参与者

Core Iv Therapy, LLC.、Cryojuvenate Uk Ltd.、B. Braun Melsungen Ag.、辉瑞公司、Jw Life Science.、Amanta Healthcare.、Vifor Pharma Management Ltd.、大冢製药有限公司、Baxter.、重症监护病房医疗。是全球 IV 水化治疗市场的一些领先参与者。

报告范围：

在本报告中，除了以下详细介绍的产业趋势外，全球静脉水化治疗市场还分为以下几类：

IV 水化治疗市场，依服务分类：

  • 免疫增强剂
  • 能量助推器
  • 皮肤护理
  • 其他的

IV 水化治疗市场，依组成部分：

  • 紧急医疗保健
  • 日常保健

IV 水化治疗市场，依最终使用者划分：

  • 医院和诊所
  • 健康中心和水疗中心
  • 家庭医疗保健
  • 其他的

IV 水化治疗市场，按地区：

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

竞争格局

公司概况：全球静脉水化治疗市场主要公司的详细分析。

可用的客製化：

根据给定的市场资料，TechSci Research 可根据公司的具体需求提供客製化服务。该报告可以使用以下自订选项：

公司资讯

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球 IV 水化疗法市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依服务分类（免疫增强剂、能量增强剂、皮肤护理、偏头痛、其他）
    • 按成分（药物、非药物）
    • 最终使用者（医院和诊所、健康中心和水疗中心、家庭医疗保健、其他）
    • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
    • 按公司划分 (2022)
  • 市场地图
    • 按服务
    • 按组件
    • 由最终用户
    • 按地区

第 6 章：北美 IV 水化疗法市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按服务
    • 按组件
    • 由最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲 IV 水化疗法市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按服务
    • 按组件
    • 由最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章：亚太地区 IV 水化治疗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按服务
    • 按组件
    • 由最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲 IV 水化疗法市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按服务
    • 按组件
    • 由最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲 IV 水化疗法市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按服务
    • 按组件
    • 由最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非 IV 水化疗法
    • 沙乌地阿拉伯 IV 水化疗法
    • 阿联酋 IV 水化疗法

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球 IV 水化治疗市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 产品供应
  • 最近的发展
  • 财务（据报导）
  • 主要人员
  • SWOT分析
    • Core Iv Therapy, Llc.
    • Cryojuvenate Uk Ltd.
    • B. Braun Melsungen Ag.
    • Pfizer, Inc.
    • Jw Life Science.
    • Amanta Healthcare.
    • Vifor Pharma Management Ltd.
    • Otsuka Pharmaceutical Co., Ltd.
    • Baxter.
    • ICU MEDICAL.

第 16 章：策略建议

第 17 章：关于我们与免责声明

简介目录
Product Code: 15343

Global IV Hydration Therapy market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the increasing number of incidences of chronic diseases, growing number of surgeries across the globe, and rising number of intravenous drug approvals. Also, increasing establishments of clinics offering IV therapies to increase the geographical presence of the companies is anticipated to drive the growth of the market during the forecast period. Similarly, rising prevalence of malnutrition, shorter response time, and higher efficacy associated with intravenous solution therapy are the major drivers for the growth of the market over the years. Similarly, growing adoption of nutrition for patients who do not receive any other form of nutrition, will further propel the growth of the market over the years. Additionally, an increasing aging population where patients need to be fed nutritionally necessary products via intravenous routes will further drive the growth of the market during the forecast period. For instance, in July 2022, Sameday Health, a major testing & wellness provider, introduced the Inner Beauty IV drip therapy in the U.S. The service will be provided at Sameday Health clinics in the region where the wellness facilities are offered to help clients' collagen production, strengthen their nails and hair, keep their skin healthy, and provide other benefits.

Increasing Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases is a key driver of the growth of the Global IV Hydration Therapy market. Chronic diseases such as diabetes, cardiovascular diseases, and cancer, can cause dehydration and nutrient deficiencies. IV hydration therapy is often used as a complementary therapy to manage the symptoms and complications of these diseases. Patients with chronic diseases often require frequent hospitalizations or outpatient treatments, which can lead to dehydration due to the illness or the treatments themselves. IV hydration therapy is an effective way to replenish fluids and nutrients quickly and efficiently, reducing the risk of complications and improving patient outcomes. Additionally, IV hydration therapy can help manage the side effects of chemotherapy and radiation therapy in cancer patients. These treatments can cause severe nausea and vomiting, leading to dehydration and malnutrition. IV hydration therapy can help manage these side effects and improve the patient's overall quality of life. As the global population ages and the prevalence of chronic diseases continues to increase, the demand for IV hydration therapy is expected to grow. This growth is not just limited to hospitals and clinics, as IV hydration therapy has become popular in non-medical settings such as spas, gyms, and even private homes.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 2.71 Billion
Market Size 2028USD 4.06 Billion
CAGR (2023-2028)6.86%
Fastest Growing SegmentEnergy Boosters
Largest MarketNorth America

Rising Popularity of Wellness and Preventative Healthcare

The rising popularity of wellness and preventative healthcare is a significant driver of the growth of the Global IV Hydration Therapy Market. As people become more health-conscious, there is a growing interest in preventative healthcare and maintaining optimal health. IV hydration therapy is becoming a popular way to achieve this goal. IV hydration therapy is an effective way to boost the immune system, replenish fluids and electrolytes, and improve overall health and wellness. It is often used by athletes and fitness enthusiasts to aid in recovery after a workout or competition, as well as to improve performance. In addition, IV hydration therapy is increasingly being used as a way to combat the effects of aging, including fatigue, wrinkles, and other signs of aging. It is also used to combat the effects of stress and burnout, which are common in modern society. IV hydration therapy is also gaining popularity as a way to combat hangovers and jet lag, as it can quickly rehydrate the body and alleviate symptoms. As the demand for preventative healthcare and wellness services continues to grow, the demand for IV hydration therapy is expected to increase as well. This growth is also aided by the growing use in non-medical settings such as spas and fitness centers.

Growing Demand For Minimally Invasive Medical Treatments

The growing demand for minimally invasive medical treatments is a significant driver of the growth of the Global IV Hydration Therapy Market. Minimally invasive medical treatments are those that involve less risk, pain, and recovery time than traditional surgical procedures. IV hydration therapy is a minimally invasive treatment that can provide fast and effective results with minimal discomfort or downtime. IV hydration therapy is a non-invasive treatment that involves administering fluids, electrolytes, and nutrients directly into the bloodstream through a vein. This allows for rapid absorption of these substances, which can quickly replenish fluids and nutrients and address a wide range of health issues. The minimally invasive nature of IV hydration therapy makes it an attractive treatment option for patients who want to avoid surgery or other invasive treatments. It is also a popular choice for patients who have difficulty taking oral medications or supplements due to nausea, vomiting, or other digestive issues. Additionally, IV hydration therapy can be administered in a variety of settings, including hospitals, clinics, and even in-home settings, which makes it a convenient treatment option for patients. As the demand for minimally invasive medical treatments continues to grow, the demand for IV hydration therapy is expected to increase as well. This growth is not limited to medical settings, as IV hydration therapy is also becoming popular in non-medical settings such as spas, gyms, and private homes.

Increasing Adoption of IV Hydration Therapy in Non-Medical Settings

The increasing adoption of IV hydration therapy in non-medical settings is a significant driver in the growth of the Global IV Hydration Therapy market. IV hydration therapy is no longer limited to hospitals and clinics but is becoming a popular treatment option in non-medical settings such as spas, fitness centers, and even private homes. One reason for the increasing adoption of IV hydration therapy in non-medical settings is the growing popularity of wellness and preventative healthcare. Another reason for the increasing adoption of IV hydration therapy in non-medical settings is the convenience factor. Patients can receive IV hydration therapy in a spa or fitness center while they work out or relax, making it a convenient and efficient way to receive treatment. Additionally, the adoption of IV hydration therapy in non-medical settings is being driven by the increasing availability of mobile IV hydration therapy services. These services bring IV hydration therapy directly to patients, whether they are at home or at a remote location, making it even more convenient and accessible. The increasing adoption of IV hydration therapy in non-medical settings is expected to continue to drive the growth of the Global IV Hydration Therapy market. As more people become aware of the benefits of IV hydration therapy and the convenience of receiving treatment in non-medical settings, the demand for these services is expected to increase further.

Use of IV Hydration Therapy as a Treatment For COVID-19

The use of IV hydration therapy as a treatment for COVID-19 is expected to significantly influence the growth of the Global IV Hydration Therapy market. COVID-19 is a respiratory illness caused by the novel coronavirus, and it can cause dehydration and electrolyte imbalances in some patients, particularly in those with severe cases. IV hydration therapy is a potential treatment for COVID-19 because it can help to address dehydration and electrolyte imbalances, further improving overall health and aiding in recovery. It can also be used to deliver medications and supplements that can help to boost the immune system and fight the virus. In addition, IV hydration therapy has been used to treat patients with other respiratory illnesses, such as influenza and pneumonia, and has been shown to improve outcomes in some cases. As the COVID-19 pandemic continues to spread globally, the demand for IV hydration therapy as a potential treatment for the disease is expected to increase. This is likely to lead to increased investment in research and development of IV hydration therapy, specifically for the treatment of COVID-19. Furthermore, the increasing use of IV hydration therapy for COVID-19 treatment is likely to lead to increased adoption of the therapy in medical settings and may even drive the expansion of IV hydration therapy services into non-medical settings.

Growing Aging Population

The growing aging population is expected to significantly influence the growth of the Global IV Hydration Therapy market. As people age, their bodies become less efficient at absorbing nutrients and fluids, leading to dehydration and other health issues. IV hydration therapy is a potential solution for dehydration and nutrient deficiencies that are common in elderly patients. IV hydration therapy can quickly and efficiently deliver fluids, electrolytes, and other essential nutrients directly into the bloodstream, bypassing the digestive system and ensuring rapid absorption. Furthermore, as the elderly population grows, there is an increasing demand for home healthcare services, which can include IV hydration therapy. Many elderly patients prefer to receive healthcare services in the comfort of their own homes, to which mobile IV hydration therapy services can provide this option. In addition, the elderly population is more likely to suffer from chronic illnesses such as cancer, kidney disease, and heart disease, thereby increasing the need for IV hydration therapy as part of their treatment regimen. Overall, the growing aging population is expected to drive the demand for IV hydration therapy as a solution for dehydration and nutrient deficiencies in elderly patients. This demand is likely to lead to increased investment in research and growing development of IV hydration therapy specifically for all population and the growing expansion of IV hydration therapy services into home healthcare settings.

Recent Development

  • In 2020, DripDrop ORS is an oral rehydration solution that is designed to provide hydration and electrolytes to people who are dehydrated due to illness, exercise, or other factors. The product is available in a range of flavors and can be purchased online or in select retail stores.
  • In 2022, Vida-Flo Hydration Station is a franchise-based IV hydration therapy service that provides on-demand IV hydration therapy to customers at various locations across the United States. The service offers a range of IV hydration therapy options, including vitamin-infused IVs and immune-boosting IVs.
  • In 2020, Nuun Sport Electrolyte Tablets are designed to provide hydration and electrolytes to athletes and active individuals. The tablets dissolve in water and can be consumed before, during, or after exercise to help maintain hydration and electrolyte balance.
  • In 2020, Reviv Global is a global franchise-based IV hydration therapy service that provides on-demand IV hydration therapy to customers at various locations around the world. The service offers a range of IV hydration therapy options, including vitamin-infused IVs and immune-boosting IVs.
  • In 2020, Essential Elements Hydration Powder is a powder-based electrolyte supplement that is designed to provide hydration and electrolytes to people who are dehydrated due to illness, exercise, or other factors. The product is available in a range of flavors and can be purchased online or in select retail stores.

Market Segmentation

Global IV Hydration Therapy market can be segmented by Service, Component, End Users, and by Region. Based on Service, the market can be segmented into Immune Booster, Energy Booster, Skin Care, and Others. Based on Component, the market can be divided into Emergency Healthcare and Routine Healthcare. Based on End Users, the market can be segmented into Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, and Others.

Market Players

Core Iv Therapy, LLC., Cryojuvenate Uk Ltd., B. Braun Melsungen Ag., Pfizer, Inc., Jw Life Science., Amanta Healthcare., Vifor Pharma Management Ltd., Otsuka Pharmaceutical Co., Ltd., Baxter., ICU MEDICAL. are some of the leading players operating in the Global IV Hydration Therapy Market.

Report Scope:

In this report, Global IV Hydration Therapy market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

IV Hydration Therapy Market, By Service:

  • Immune Booster
  • Energy Boosters
  • Skin Care
  • Others

IV Hydration Therapy Market, By Component:

  • Emergency Healthcare
  • Routine Healthcare

IV Hydration Therapy Market, By End Users:

  • Hospitals & Clinics
  • Wellness Centers & Spa
  • Home Healthcare
  • Others

IV Hydration Therapy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global IV Hydration Therapy Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global IV Hydration Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Immune Booster, Energy Booster, Skin Care, Migraine, Others)
    • 5.2.2. By Component (Medicated, Non-Medicated)
    • 5.2.3. By End Users (Hospitals & Clinics, Wellness Centers & Spa, Home Healthcare, Others)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Service
    • 5.3.2 By Component
    • 5.3.3 By End Users
    • 5.3.4 By Region

6. North America IV Hydration Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Component
    • 6.2.3. By End Users
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States IV Hydration Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Component
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada IV Hydration Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Component
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico IV Hydration Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Component
        • 6.3.3.2.3. By End User

7. Europe IV Hydration Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Component
    • 7.2.3. By End Users
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France IV Hydration Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Component
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany IV Hydration Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Component
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom IV Hydration Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Component
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy IV Hydration Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Component
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain IV Hydration Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Component
        • 7.3.5.2.3. By End User

8. Asia-Pacific IV Hydration Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Component
    • 8.2.3. By End Users
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China IV Hydration Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Component
        • 8.3.1.2.3. By End User
    • 8.3.2. India IV Hydration Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Component
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan IV Hydration Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Component
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea IV Hydration Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Component
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia IV Hydration Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Component
        • 8.3.5.2.3. By End User

9. South America IV Hydration Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Component
    • 9.2.3. By End Users
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil IV Hydration Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Component
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina IV Hydration Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Component
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia IV Hydration Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Component
        • 9.3.3.2.3. By End User

10. Middle East and Africa IV Hydration Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Component
    • 10.2.3. By End Users
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa IV Hydration Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Component
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia IV Hydration Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Component
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE IV Hydration Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Component
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global IV Hydration Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Core Iv Therapy, Llc.
    • 15.6.2 Cryojuvenate Uk Ltd.
    • 15.6.3 B. Braun Melsungen Ag.
    • 15.6.4 Pfizer, Inc.
    • 15.6.5 Jw Life Science.
    • 15.6.6 Amanta Healthcare.
    • 15.6.7 Vifor Pharma Management Ltd.
    • 15.6.8 Otsuka Pharmaceutical Co., Ltd.
    • 15.6.9 Baxter.
    • 15.6.10 ICU MEDICAL.

16. Strategic Recommendations

17. About Us & Disclaimer